Studies focused on the understanding of the molecular mechanisms involved in recovery or progression to chronicity of HBV may take advantage of natural and experimental models that mimic its properties. This is also of relevance for associated diseases such as cirrhosis and hepatocellulocarcinoma. The eastern woodchuck (Marmota monax) infected by the hepadnavirus woodchuck Hepatitis B virus (WHV) has been applied as a predictive model to support development of new HBV vaccines, antivirals, immunotherapies and combination therapies. This report summarizes studies carried out by our and other groups, with the application of this model in natural and experimental infections. Using standardized viral inocula in neonate and adult animals and newly established assays, the presence of the specific patterns of markers of acute, chronic and resolved infections and their relationships in the different virus-host interactions have been shown. B and T cell responses and T(H)1 cytokine expression have been shown to play a crucial role in the outcome of infection. The availability of the WHV/Marmota monax model and specific standardized assays may allow evaluation of new formulations of multimodal therapeutic strategies based on antiviral chemotherapy and immunomodulation. These may also include specifically targeted immunocomplexes. Such therapies could constitute new frontiers for the treatment of HBV chronic disease.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1517/17460441.2010.530252 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
An optimized protocol for quality control of gene therapy vectors using nanopore direct RNA sequencing.
Genome Res
November 2024
Research Data Science Group, R&D, CSL, Parkville, Victoria 3000, Australia.
Article Synopsis
- * Nanopore direct RNA sequencing was found to be the best method for detecting RNA issues, including cryptic splicing and polyadenylation sites in lentiviral vectors.
- * This sequencing technique can help optimize vector design, leading to better quality and more reliable lentiviral gene therapies.
Sub-genomic flaviviral RNA elements increase the stability and abundance of recombinant AAV vector transcripts.
J Virol
August 2024
Department of Surgery, Duke University School of Medicine, Durham, North Carolina, USA.
Unlabelled: Many viruses have evolved structured RNA elements that can influence transcript abundance and translational efficiency, and help evade host immune factors by hijacking cellular machinery during replication. Here, we evaluated the functional impact of sub-genomic flaviviral RNAs (sfRNAs) known to stall exoribonuclease activity, by incorporating these elements into recombinant adeno-associated viral (AAV) genome cassettes. Specifically, sfRNAs from Dengue, Zika, Japanese Encephalitis, Yellow Fever, Murray Valley Encephalitis, and West Nile viruses increased transcript stability and transgene expression compared to a conventional woodchuck hepatitis virus element (WPRE).
View Article and Find Full Text PDFAn Open-Label Phase II Study Assessing the Safety of Bilateral, Sequential Administration of Retinal Gene Therapy in Participants with Choroideremia: The GEMINI Study.
Hum Gene Ther
August 2024
Biogen Inc., Cambridge, Massachusetts, USA.
Choroideremia, an incurable, progressive retinal degeneration primarily affecting young men, leads to sight loss. GEMINI was a multicenter, open-label, prospective, two-period, interventional Phase II study assessing the safety of bilateral sequential administration of timrepigene emparvovec, a gene therapy, in adult males with genetically confirmed choroideremia (NCT03507686, ClinicalTrials.gov).
View Article and Find Full Text PDFDeveloping Gene Therapy for Mitigating Multisystemic Pathology in Fabry Disease: Proof of Concept in an Aggravated Mouse Model.
Hum Gene Ther
September 2024
Takeda Pharmaceuticals USA, Inc., Cambridge, Massachusetts, USA.
Fabry disease (FD) is a multisystemic lysosomal storage disorder caused by the loss of α-galactosidase A (α-Gal) function. The current standard of care, enzyme replacement therapies, while effective in reducing kidney pathology when treated early, do not fully ameliorate cardiac issues, neuropathic manifestations, and risk of cerebrovascular events. Adeno-associated virus (AAV)-based gene therapies (AAV-GT) can provide superior efficacy across multiple tissues owing to continuous, endogenous production of the therapeutic enzyme and lower treatment burden.
View Article and Find Full Text PDFAnalysis of Replication, Cell Division-Mediated Spread, and HBV Envelope Protein-Dependent Pseudotyping of Three Mammalian Delta-like Agents.
Viruses
May 2024
Department of Infectious Diseases, Molecular Virology, University Hospital Heidelberg, 69120 Heidelberg, Germany.
Article Synopsis
- The human hepatitis delta virus (HDV) is a satellite virus that relies on hepatitis B virus (HBV) proteins for its assembly and targets the liver, and recent bioinformatics research has clarified its evolutionary origins and complexity.
- This study examines three mammalian HDV-like agents (DLAs) discovered in woodchuck, white-tailed deer, and lesser dog-like bat, focusing on their replication and ability to spread in various cell types.
- Findings indicate that these DLAs can replicate independently in both liver and non-liver tissues without needing helper virus envelope proteins, and their interactions with HBV proteins can lead to the formation of infectious particles for further study.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!